scispace - formally typeset
Open AccessJournal ArticleDOI

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project

Reads0
Chats0
TLDR
Recurrent DCIS or invasive cancer is uncommon after screen-detected DCIS and both RT and endocrine therapy were associated with a reduction in further events but not with breast cancer mortality within 5 years of diagnosis.
About
This article is published in European Journal of Cancer.The article was published on 2018-08-06 and is currently open access. It has received 46 citations till now. The article focuses on the topics: Breast cancer & Breast-conserving surgery.

read more

Citations
More filters
Journal ArticleDOI

Accounting for Preinvasive Conditions in Analysis of Invasive Cancer Risk: Application to Breast Cancer.

TL;DR: In this article, the authors proposed two solutions: one that provides exact estimates of risk based on distributional assumptions about progression, and another that provides risk bounds corresponding to extreme cases of no or complete progression.
References
More filters
Journal ArticleDOI

The benefits and harms of breast cancer screening: an independent review

TL;DR: It is concluded that screening reduces breast cancer mortality but that some overdiagnosis occurs, and results from observational studies support the occurrence of over Diagnosis, but estimates of its magnitude are unreliable.
Journal ArticleDOI

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

TL;DR: Although I-IBTR increased the risk for breast cancer-related death, radiation therapy and tamoxifen reduced I- IBTR, and long-term prognosis remained excellent after breast-conserving surgery for DCIS.
Journal ArticleDOI

The Influence of Margin Width on Local Control of Ductal Carcinoma in Situ of the Breast

TL;DR: Postoperative radiation therapy did not lower the recurrence rate among patients with ductal carcinoma in situ that was excised with margins of 10 mm or more, but patients in whom the margin width is less than 1 mm can benefit from postoperative radiation Therapy.
Journal ArticleDOI

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

TL;DR: This updated analysis confirms the long-term beneficial effect of radiotherapy and reports a benefit for tamoxifen in reducing local and contralateral new breast events for women with DCIS treated by complete local excision.
Journal ArticleDOI

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

TL;DR: The risk of death increases after a diagnosis of an ipsilateral second primary invasive breast cancer, but prevention of these recurrences by radiotherapy does not diminish breast cancer mortality at 10 years.
Related Papers (5)
Frequently Asked Questions (9)
Q1. What was the effect of RT on ipsilateral recurrence?

Adjuvant endocrine therapy (1208/9938; 12%) was associated with a reduction in any ipsilateral recurrence, whether RT was received (HR 0.57: 95% CI 0.41 - 0.80) or not (HR 0.68: 95% CI 0.51 - 0.91) after BCS. 

Ipsilateral breast recurrence after BCS was 5.3% (368/7007); ipsilateral chest wall recurrence after mastectomy was 0.8% (24/2931). 

Endocrine therapy was associated with a non-significant reduction in ipsilateral breast recurrence independent of RT, although the greatest effect was seen for the reduction of invasive further events in the absence of RT. 

Participating units were required to follow a pathology protocol containing definitions for DCIS, microinvasion, cytonuclear grade, comedo necrosis and assessment of excision margins and to handle and report specimens to NHSBSP pathology standards. [8] 

The United Kingdom National Health Service Breast Screening Programme (NHSBSP) invites women aged 50-70 to attend breast screening every three years (supplementary figure and text p2). 

mastectomy was, not unexpectedly, associated with features of more aggressive DCIS.RT following BCS was associated with a significant reduction in all ipsilateral breast further events (DCIS or invasive) at a median follow up of 64 months. 

12]The increasing incidence of DCIS, likely to be sustained with the enhanced visualisation that digital mammography provides, now deployed in the UK NHS BSP, emphasises the potential for overtreatment of women diagnosed though breast screening. [1] 

Radiology guidelines mandated participating radiologists should complete detailed radiology proformas [9] and participate in the NHSBSP PERFORMS external quality assurance scheme. [10] 

The use of mastectomy was associated with DCIS of high or intermediate rather than low grade (p<0.001) and with larger lesion size (p<0.001).